The paradox of reduced intelligence-related vs. increased longevity-related polygenic risk scores further implies genomic background modulates disease trajectories through systemic metabolic or immune pathways, transcending the traditional view of DS as a pure Nav1.1 channelopathy (Martins Custodio et al., 2023). The gene discussed is SCN1A; the disease is channelopathy.